English
简体中文
Total: £ 56.28
Published Date: 2026-03-31 | Pages: 138 | Tables: 124 | Medical Care
The global Bioengineered Skin Substitutes market was valued at US$ 2102 million in 2025 and is anticipated to reach US$ 4543 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Bioengineered skin consists of the outer epidermis and/or dermis (the layer of skin between the epidermis and subcutaneous tissue) embedded in an acellular matrix (supporting structure) to form a biological skin substitute. Products are made from a variety of sources, including human tissue (from patients or others), non-human tissue (bovine, porcine, horse), synthetic materials (man-made), or a combination of these materials.
Global important companies in bioengineered skin substitutes includes Allergan, AlloSource, Organogenesis, and BD. The head company shares over 30% of the market. Geographically speaking, Americas holds about 50% of global market share, followed by Europe with about 35% share. Bioengineered skin substitutes includes Allogeneic Acellular, Xenogeneic, Allogeneic Cells, and Autologous. Allogeneic Acellular is the largest part of bioengineered skin substitutes industry, has a share about 80%. Other key parts include Xenogeneic who shares nearly 15% , and Autologous who shares about 5%. The application of bioengineered skin substitutes includes hospitals,specialty clinics and wound care centers. Hospitals shares the largest percent of 60.30%.
Market development trends
Technological innovation: With the continuous advancement of science and technology, the bioengineered skin substitute industry will continue to promote technological innovation and industrial upgrading. By introducing new preparation technologies and materials, the performance and quality of products will be continuously improved to meet the growing market demand.
Personalized customization: As consumers' pursuit of beauty becomes increasingly refined and personalized, personalized customization will become an important trend in the bioengineered skin substitute market. Through the application of new technologies such as gene editing technology and bioengineering technology, more accurate and efficient treatment plans are provided to patients.
Market expansion: With the vigorous development of the medical beauty industry, the market space for bioengineered skin substitutes will be further expanded. At the same time, enterprises will also actively expand the international market and improve the international competitiveness of their products.
This report delivers a comprehensive overview of the global Bioengineered Skin Substitutes market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Bioengineered Skin Substitutes. The Bioengineered Skin Substitutes market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Bioengineered Skin Substitutes market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Bioengineered Skin Substitutes manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Allergan
AlloSource
Organogenesis
BD
Smith & Nephew
Integra LifeSciences
Synthes (Johnson & Johnson)
Axogen
Vericel Corporation
LifeNet Health
MTF Biologics
Arthrex
Stryker
Cook Biotech
Aroa Biosurgery
Surgalign Holdings
Anika Therapeutics
Forticell Bioscience
MLM Biologics
Promethean LifeSciences
Segment by Type
Allogeneic Acellular
Xenogeneic
Allogeneic Cells
Autologous
Segment by Application
Hospitals
Specialty Clinics
Wound Care Centers
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Bioengineered Skin Substitutes companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bioengineered Skin Substitutes Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Allogeneic Acellular
1.2.3 Xenogeneic
1.2.4 Allogeneic Cells
1.2.5 Autologous
1.3 Market by Application
1.3.1 Global Bioengineered Skin Substitutes Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Wound Care Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bioengineered Skin Substitutes Market Perspective (2021–2032)
2.2 Global Bioengineered Skin Substitutes Growth Trends by Region
2.2.1 Global Bioengineered Skin Substitutes Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Bioengineered Skin Substitutes Historic Market Size by Region (2021–2026)
2.2.3 Bioengineered Skin Substitutes Forecasted Market Size by Region (2027–2032)
2.3 Bioengineered Skin Substitutes Market Dynamics
2.3.1 Bioengineered Skin Substitutes Industry Trends
2.3.2 Bioengineered Skin Substitutes Market Drivers
2.3.3 Bioengineered Skin Substitutes Market Challenges
2.3.4 Bioengineered Skin Substitutes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bioengineered Skin Substitutes Players by Revenue
3.1.1 Global Top Bioengineered Skin Substitutes Players by Revenue (2021–2026)
3.1.2 Global Bioengineered Skin Substitutes Revenue Market Share by Players (2021–2026)
3.2 Global Top Bioengineered Skin Substitutes Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Bioengineered Skin Substitutes Revenue
3.4 Global Bioengineered Skin Substitutes Market Concentration Ratio
3.4.1 Global Bioengineered Skin Substitutes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioengineered Skin Substitutes Revenue in 2025
3.5 Global Key Players of Bioengineered Skin Substitutes Head Offices and Areas Served
3.6 Global Key Players of Bioengineered Skin Substitutes, Products and Applications
3.7 Global Key Players of Bioengineered Skin Substitutes, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Bioengineered Skin Substitutes Breakdown Data by Type
4.1 Global Bioengineered Skin Substitutes Historic Market Size by Type (2021–2026)
4.2 Global Bioengineered Skin Substitutes Forecasted Market Size by Type (2027–2032)
5 Bioengineered Skin Substitutes Breakdown Data by Application
5.1 Global Bioengineered Skin Substitutes Historic Market Size by Application (2021–2026)
5.2 Global Bioengineered Skin Substitutes Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Bioengineered Skin Substitutes Market Size (2021–2032)
6.2 North America Bioengineered Skin Substitutes Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Bioengineered Skin Substitutes Market Size by Country (2021–2026)
6.4 North America Bioengineered Skin Substitutes Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bioengineered Skin Substitutes Market Size (2021–2032)
7.2 Europe Bioengineered Skin Substitutes Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Bioengineered Skin Substitutes Market Size by Country (2021–2026)
7.4 Europe Bioengineered Skin Substitutes Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Bioengineered Skin Substitutes Market Size (2021–2032)
8.2 Asia-Pacific Bioengineered Skin Substitutes Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Bioengineered Skin Substitutes Market Size by Region (2021–2026)
8.4 Asia-Pacific Bioengineered Skin Substitutes Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Bioengineered Skin Substitutes Market Size (2021–2032)
9.2 Latin America Bioengineered Skin Substitutes Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Bioengineered Skin Substitutes Market Size by Country (2021–2026)
9.4 Latin America Bioengineered Skin Substitutes Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bioengineered Skin Substitutes Market Size (2021–2032)
10.2 Middle East & Africa Bioengineered Skin Substitutes Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Bioengineered Skin Substitutes Market Size by Country (2021–2026)
10.4 Middle East & Africa Bioengineered Skin Substitutes Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Bioengineered Skin Substitutes Introduction
11.1.4 Allergan Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.1.5 Allergan Recent Development
11.2 AlloSource
11.2.1 AlloSource Company Details
11.2.2 AlloSource Business Overview
11.2.3 AlloSource Bioengineered Skin Substitutes Introduction
11.2.4 AlloSource Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.2.5 AlloSource Recent Development
11.3 Organogenesis
11.3.1 Organogenesis Company Details
11.3.2 Organogenesis Business Overview
11.3.3 Organogenesis Bioengineered Skin Substitutes Introduction
11.3.4 Organogenesis Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.3.5 Organogenesis Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Bioengineered Skin Substitutes Introduction
11.4.4 BD Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.4.5 BD Recent Development
11.5 Smith & Nephew
11.5.1 Smith & Nephew Company Details
11.5.2 Smith & Nephew Business Overview
11.5.3 Smith & Nephew Bioengineered Skin Substitutes Introduction
11.5.4 Smith & Nephew Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.5.5 Smith & Nephew Recent Development
11.6 Integra LifeSciences
11.6.1 Integra LifeSciences Company Details
11.6.2 Integra LifeSciences Business Overview
11.6.3 Integra LifeSciences Bioengineered Skin Substitutes Introduction
11.6.4 Integra LifeSciences Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.6.5 Integra LifeSciences Recent Development
11.7 Synthes (Johnson & Johnson)
11.7.1 Synthes (Johnson & Johnson) Company Details
11.7.2 Synthes (Johnson & Johnson) Business Overview
11.7.3 Synthes (Johnson & Johnson) Bioengineered Skin Substitutes Introduction
11.7.4 Synthes (Johnson & Johnson) Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.7.5 Synthes (Johnson & Johnson) Recent Development
11.8 Axogen
11.8.1 Axogen Company Details
11.8.2 Axogen Business Overview
11.8.3 Axogen Bioengineered Skin Substitutes Introduction
11.8.4 Axogen Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.8.5 Axogen Recent Development
11.9 Vericel Corporation
11.9.1 Vericel Corporation Company Details
11.9.2 Vericel Corporation Business Overview
11.9.3 Vericel Corporation Bioengineered Skin Substitutes Introduction
11.9.4 Vericel Corporation Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.9.5 Vericel Corporation Recent Development
11.10 LifeNet Health
11.10.1 LifeNet Health Company Details
11.10.2 LifeNet Health Business Overview
11.10.3 LifeNet Health Bioengineered Skin Substitutes Introduction
11.10.4 LifeNet Health Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.10.5 LifeNet Health Recent Development
11.11 MTF Biologics
11.11.1 MTF Biologics Company Details
11.11.2 MTF Biologics Business Overview
11.11.3 MTF Biologics Bioengineered Skin Substitutes Introduction
11.11.4 MTF Biologics Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.11.5 MTF Biologics Recent Development
11.12 Arthrex
11.12.1 Arthrex Company Details
11.12.2 Arthrex Business Overview
11.12.3 Arthrex Bioengineered Skin Substitutes Introduction
11.12.4 Arthrex Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.12.5 Arthrex Recent Development
11.13 Stryker
11.13.1 Stryker Company Details
11.13.2 Stryker Business Overview
11.13.3 Stryker Bioengineered Skin Substitutes Introduction
11.13.4 Stryker Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.13.5 Stryker Recent Development
11.14 Cook Biotech
11.14.1 Cook Biotech Company Details
11.14.2 Cook Biotech Business Overview
11.14.3 Cook Biotech Bioengineered Skin Substitutes Introduction
11.14.4 Cook Biotech Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.14.5 Cook Biotech Recent Development
11.15 Aroa Biosurgery
11.15.1 Aroa Biosurgery Company Details
11.15.2 Aroa Biosurgery Business Overview
11.15.3 Aroa Biosurgery Bioengineered Skin Substitutes Introduction
11.15.4 Aroa Biosurgery Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.15.5 Aroa Biosurgery Recent Development
11.16 Surgalign Holdings
11.16.1 Surgalign Holdings Company Details
11.16.2 Surgalign Holdings Business Overview
11.16.3 Surgalign Holdings Bioengineered Skin Substitutes Introduction
11.16.4 Surgalign Holdings Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.16.5 Surgalign Holdings Recent Development
11.17 Anika Therapeutics
11.17.1 Anika Therapeutics Company Details
11.17.2 Anika Therapeutics Business Overview
11.17.3 Anika Therapeutics Bioengineered Skin Substitutes Introduction
11.17.4 Anika Therapeutics Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.17.5 Anika Therapeutics Recent Development
11.18 Forticell Bioscience
11.18.1 Forticell Bioscience Company Details
11.18.2 Forticell Bioscience Business Overview
11.18.3 Forticell Bioscience Bioengineered Skin Substitutes Introduction
11.18.4 Forticell Bioscience Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.18.5 Forticell Bioscience Recent Development
11.19 MLM Biologics
11.19.1 MLM Biologics Company Details
11.19.2 MLM Biologics Business Overview
11.19.3 MLM Biologics Bioengineered Skin Substitutes Introduction
11.19.4 MLM Biologics Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.19.5 MLM Biologics Recent Development
11.20 Promethean LifeSciences
11.20.1 Promethean LifeSciences Company Details
11.20.2 Promethean LifeSciences Business Overview
11.20.3 Promethean LifeSciences Bioengineered Skin Substitutes Introduction
11.20.4 Promethean LifeSciences Revenue in Bioengineered Skin Substitutes Business (2021–2026)
11.20.5 Promethean LifeSciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Bioengineered Skin Substitutes Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Allogeneic Acellular
Table 3. Key Players of Xenogeneic
Table 4. Key Players of Allogeneic Cells
Table 5. Key Players of Autologous
Table 6. Global Bioengineered Skin Substitutes Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Bioengineered Skin Substitutes Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Bioengineered Skin Substitutes Market Size by Region (US$ Million), 2021–2026
Table 9. Global Bioengineered Skin Substitutes Market Share by Region (2021–2026)
Table 10. Global Bioengineered Skin Substitutes Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Bioengineered Skin Substitutes Market Share by Region (2027–2032)
Table 12. Bioengineered Skin Substitutes Market Trends
Table 13. Bioengineered Skin Substitutes Market Drivers
Table 14. Bioengineered Skin Substitutes Market Challenges
Table 15. Bioengineered Skin Substitutes Market Restraints
Table 16. Global Bioengineered Skin Substitutes Revenue by Players (US$ Million), 2021–2026
Table 17. Global Bioengineered Skin Substitutes Market Share by Players (2021–2026)
Table 18. Global Top Bioengineered Skin Substitutes Players by Tier (Tier 1, Tier 2, and Tier 3), based on Bioengineered Skin Substitutes Revenue, 2025
Table 19. Ranking of Global Top Bioengineered Skin Substitutes Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Bioengineered Skin Substitutes Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Bioengineered Skin Substitutes, Headquarters and Area Served
Table 22. Global Key Players of Bioengineered Skin Substitutes, Products and Applications
Table 23. Global Key Players of Bioengineered Skin Substitutes, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Bioengineered Skin Substitutes Market Size by Type (US$ Million), 2021–2026
Table 26. Global Bioengineered Skin Substitutes Revenue Market Share by Type (2021–2026)
Table 27. Global Bioengineered Skin Substitutes Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Bioengineered Skin Substitutes Revenue Market Share by Type (2027–2032)
Table 29. Global Bioengineered Skin Substitutes Market Size by Application (US$ Million), 2021–2026
Table 30. Global Bioengineered Skin Substitutes Revenue Market Share by Application (2021–2026)
Table 31. Global Bioengineered Skin Substitutes Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Bioengineered Skin Substitutes Revenue Market Share by Application (2027–2032)
Table 33. North America Bioengineered Skin Substitutes Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Bioengineered Skin Substitutes Market Size by Country (US$ Million), 2021–2026
Table 35. North America Bioengineered Skin Substitutes Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Bioengineered Skin Substitutes Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Bioengineered Skin Substitutes Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Bioengineered Skin Substitutes Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Bioengineered Skin Substitutes Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Bioengineered Skin Substitutes Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Bioengineered Skin Substitutes Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Bioengineered Skin Substitutes Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Bioengineered Skin Substitutes Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Bioengineered Skin Substitutes Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Bioengineered Skin Substitutes Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Bioengineered Skin Substitutes Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Bioengineered Skin Substitutes Market Size by Country (US$ Million), 2027–2032
Table 48. Allergan Company Details
Table 49. Allergan Business Overview
Table 50. Allergan Bioengineered Skin Substitutes Product
Table 51. Allergan Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 52. Allergan Recent Development
Table 53. AlloSource Company Details
Table 54. AlloSource Business Overview
Table 55. AlloSource Bioengineered Skin Substitutes Product
Table 56. AlloSource Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 57. AlloSource Recent Development
Table 58. Organogenesis Company Details
Table 59. Organogenesis Business Overview
Table 60. Organogenesis Bioengineered Skin Substitutes Product
Table 61. Organogenesis Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 62. Organogenesis Recent Development
Table 63. BD Company Details
Table 64. BD Business Overview
Table 65. BD Bioengineered Skin Substitutes Product
Table 66. BD Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 67. BD Recent Development
Table 68. Smith & Nephew Company Details
Table 69. Smith & Nephew Business Overview
Table 70. Smith & Nephew Bioengineered Skin Substitutes Product
Table 71. Smith & Nephew Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 72. Smith & Nephew Recent Development
Table 73. Integra LifeSciences Company Details
Table 74. Integra LifeSciences Business Overview
Table 75. Integra LifeSciences Bioengineered Skin Substitutes Product
Table 76. Integra LifeSciences Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 77. Integra LifeSciences Recent Development
Table 78. Synthes (Johnson & Johnson) Company Details
Table 79. Synthes (Johnson & Johnson) Business Overview
Table 80. Synthes (Johnson & Johnson) Bioengineered Skin Substitutes Product
Table 81. Synthes (Johnson & Johnson) Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 82. Synthes (Johnson & Johnson) Recent Development
Table 83. Axogen Company Details
Table 84. Axogen Business Overview
Table 85. Axogen Bioengineered Skin Substitutes Product
Table 86. Axogen Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 87. Axogen Recent Development
Table 88. Vericel Corporation Company Details
Table 89. Vericel Corporation Business Overview
Table 90. Vericel Corporation Bioengineered Skin Substitutes Product
Table 91. Vericel Corporation Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 92. Vericel Corporation Recent Development
Table 93. LifeNet Health Company Details
Table 94. LifeNet Health Business Overview
Table 95. LifeNet Health Bioengineered Skin Substitutes Product
Table 96. LifeNet Health Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 97. LifeNet Health Recent Development
Table 98. MTF Biologics Company Details
Table 99. MTF Biologics Business Overview
Table 100. MTF Biologics Bioengineered Skin Substitutes Product
Table 101. MTF Biologics Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 102. MTF Biologics Recent Development
Table 103. Arthrex Company Details
Table 104. Arthrex Business Overview
Table 105. Arthrex Bioengineered Skin Substitutes Product
Table 106. Arthrex Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 107. Arthrex Recent Development
Table 108. Stryker Company Details
Table 109. Stryker Business Overview
Table 110. Stryker Bioengineered Skin Substitutes Product
Table 111. Stryker Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 112. Stryker Recent Development
Table 113. Cook Biotech Company Details
Table 114. Cook Biotech Business Overview
Table 115. Cook Biotech Bioengineered Skin Substitutes Product
Table 116. Cook Biotech Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 117. Cook Biotech Recent Development
Table 118. Aroa Biosurgery Company Details
Table 119. Aroa Biosurgery Business Overview
Table 120. Aroa Biosurgery Bioengineered Skin Substitutes Product
Table 121. Aroa Biosurgery Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 122. Aroa Biosurgery Recent Development
Table 123. Surgalign Holdings Company Details
Table 124. Surgalign Holdings Business Overview
Table 125. Surgalign Holdings Bioengineered Skin Substitutes Product
Table 126. Surgalign Holdings Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 127. Surgalign Holdings Recent Development
Table 128. Anika Therapeutics Company Details
Table 129. Anika Therapeutics Business Overview
Table 130. Anika Therapeutics Bioengineered Skin Substitutes Product
Table 131. Anika Therapeutics Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 132. Anika Therapeutics Recent Development
Table 133. Forticell Bioscience Company Details
Table 134. Forticell Bioscience Business Overview
Table 135. Forticell Bioscience Bioengineered Skin Substitutes Product
Table 136. Forticell Bioscience Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 137. Forticell Bioscience Recent Development
Table 138. MLM Biologics Company Details
Table 139. MLM Biologics Business Overview
Table 140. MLM Biologics Bioengineered Skin Substitutes Product
Table 141. MLM Biologics Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 142. MLM Biologics Recent Development
Table 143. Promethean LifeSciences Company Details
Table 144. Promethean LifeSciences Business Overview
Table 145. Promethean LifeSciences Bioengineered Skin Substitutes Product
Table 146. Promethean LifeSciences Revenue in Bioengineered Skin Substitutes Business (US$ Million), 2021–2026
Table 147. Promethean LifeSciences Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Bioengineered Skin Substitutes Picture
Figure 2. Global Bioengineered Skin Substitutes Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Bioengineered Skin Substitutes Market Share by Type: 2025 vs 2032
Figure 4. Allogeneic Acellular Features
Figure 5. Xenogeneic Features
Figure 6. Allogeneic Cells Features
Figure 7. Autologous Features
Figure 8. Global Bioengineered Skin Substitutes Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Bioengineered Skin Substitutes Market Share by Application: 2025 vs 2032
Figure 10. Hospitals Case Studies
Figure 11. Specialty Clinics Case Studies
Figure 12. Wound Care Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Bioengineered Skin Substitutes Report Years Considered
Figure 15. Global Bioengineered Skin Substitutes Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Bioengineered Skin Substitutes Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Bioengineered Skin Substitutes Market Share by Region: 2025 vs 2032
Figure 18. Global Bioengineered Skin Substitutes Market Share by Players in 2025
Figure 19. Global Bioengineered Skin Substitutes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Bioengineered Skin Substitutes Revenue in 2025
Figure 21. North America Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Bioengineered Skin Substitutes Market Share by Country (2021–2032)
Figure 23. United States Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Bioengineered Skin Substitutes Market Share by Country (2021–2032)
Figure 27. Germany Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Bioengineered Skin Substitutes Market Share by Region (2021–2032)
Figure 35. China Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Bioengineered Skin Substitutes Market Share by Country (2021–2032)
Figure 43. Mexico Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Bioengineered Skin Substitutes Market Share by Country (2021–2032)
Figure 47. Israel Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Bioengineered Skin Substitutes Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Allergan Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 51. AlloSource Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 52. Organogenesis Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 53. BD Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 54. Smith & Nephew Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 55. Integra LifeSciences Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 56. Synthes (Johnson & Johnson) Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 57. Axogen Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 58. Vericel Corporation Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 59. LifeNet Health Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 60. MTF Biologics Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 61. Arthrex Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 62. Stryker Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 63. Cook Biotech Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 64. Aroa Biosurgery Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 65. Surgalign Holdings Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 66. Anika Therapeutics Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 67. Forticell Bioscience Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 68. MLM Biologics Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 69. Promethean LifeSciences Revenue Growth Rate in Bioengineered Skin Substitutes Business (2021–2026)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
